The staging of non-small cell lung cancer (NSCLC) involves the TNM classification system, used to assess the growth of the cancer and evaluate treatment options. The TNM system categorizes the disease ...

Tumor staging was reconfirmed according to the 8th Edition of the American Joint Committee on Cancer (AJCC) TNM Classification for Lung Cancer (18). Clinical features and disease progression were ...

The stage of prostate cancer tells you how far it has spread. TNM is a way of staging prostate cancer. It stands for Tumour, Node and Metastasis. Doctors in the UK now use a tool called the Cambridge ...

After a diagnosis is made, your doctor will stage the cancer. The stage defines the location of the cancer, how much it has spread, how big it is, and how aggressive it is. Knowing the stage of ...

The stage of a cancer tells you how big it is and how far it has spread. Knowing this helps your doctor decide the best treatment for you. TNM stands for Tumour, Node and Metastasis. Doctors use the ...

Raymond Osarogiagbon, MD, discusses the challenges of implementing lung cancer screening guidelines and the need for increased awareness and access. In this clip, Raymond Osarogiagbon, MD ...

Apr. 2, 2025 — Lung cancer screening has the potential to catch lung cancer early and save lives -- but only if people get screened. Although lung cancer screening ... A Post-Treatment Blood ...

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 ...

A German woman has a new lease on life after a novel approach to double-lung transplantation rid her of a deadly cancer. Cornelia Tischmacher, an art dealer and historian from Berlin, was ...

The test processes whole-slide images of non-small cell lung cancer tissue to provide a quantitative TROP2 score, which Roche says provides a level of precision beyond manual methods. TROP2 has ...

Margaret and her husband, David, were able to travel to Mexico because a clinical trial drug called zoldonrasib successfully controlled her lung cancer, which had returned after treatment. Dr. Kathryn ...